XML 45 R31.htm IDEA: XBRL DOCUMENT
v3.20.2

STOCK OPTION AND BENEFIT PLANS (Tables) | 12 Months Ended
--- | ---
Jun. 27, 2020
Share-based Payment Arrangement [Abstract] |
Grant Date Fair Value for Awards Estimated Using Option Valuation Method with Weighted Average Assumptions | On July 26, 2019, the Company granted 175,000 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $4.93 and a grant date fair value of $1.23. As of June 27, 2020, 150,000 remain outstanding. The grant date fair value for the awards granted during fiscal year 2020, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 26, 2019:
| Fiscal Year 2020
| July 26, 2019
Expected dividend yield | —%
Risk – free interest rate | 1.54%
Expected volatility | 28.50%
Expected life | 4.00
On July 27, 2018, the Company granted 161,250 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $8.17 and a grant date fair value of $2.27. As of June 27, 2020, 121,250 remain outstanding. The grant date fair value for the awards granted during fiscal year 2019, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 27, 2018:
| Fiscal Year 2019
| July 27, 2018
Expected dividend yield | —%
Risk – free interest rate | 2.80%
Expected volatility | 29.75%
Expected life | 4.00
On July 28, 2017, the Company granted 272,500 SARs under the 2010 Incentive Plan to certain key employees and outside directors at a strike price of $7.26 and a grant date fair value of $1.89. As of June 27, 2020, 197,500 remain outstanding. The grant date fair value for the awards granted during fiscal year 2018, were estimated using the Black Scholes option valuation method with the following weighted average assumptions as of July 28, 2017:
| Fiscal Year 2018
| July 28, 2017
Expected dividend yield | —%
Risk – free interest rate | 1.70%
Expected volatility | 29.76%
Expected life | 4.00
Summarizes Option/SARs Activity of All Plans | The following table summarizes the Company’s Options and SARs activity for all plans from July 2, 2016 through June 27, 2020:
| SARs Available For Grant |  | SARs Outstanding |  | Aggregate Intrinsic Value (in thousands) |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life (in years)
Balances, July 1, 2017 | 394,335 |  |  | 1,084,999 |  |  | $ | — |  |  | $ | 9.09 |  |  | 2.3
Shares authorized | — |  |  |  |  |  |  | — |  |  |
SARs granted | (272,500) |  |  | 272,500 |  |  |  |  | 7.26 |  |  |
SARs forfeited | 282,500 |  |  | (282,500) |  |  |  |  | 7.84 |  |  |
SARs exercised | — |  |  | — |  |  | — |  |  | — |  |  |
Balances June 30, 2018 | 404,335 |  |  | 1,074,999 |  |  | $ | 79 |  |  | $ | 8.90 |  |  | 2.3
Shares authorized | — |  |  |  |  |  |  | — |  |  |
SARs granted | (161,250) |  |  | 161,250 |  |  |  |  | 8.17 |  |  |
SARs forfeited | 250,833 |  |  | (250,833) |  |  |  |  | 10.59 |  |  |
SARs exercised | — |  |  | — |  |  | — |  |  | — |  |  |
Balances, June 29, 2019 | 493,918 |  |  | 985,416 |  |  | $ | — |  |  | $ | 8.35 |  |  | 1.7
Shares authorized | — |  |  |  |  |  |  | — |  |  |
SARs granted | (175,000) |  |  | 175,000 |  |  |  |  | 4.93 |  |  |
SARs forfeited | 290,833 |  |  | (290,833) |  |  |  |  | 7.71 |  |  |
SARs exercised | — |  |  | — |  |  | — |  |  | — |  |  |
Balances, June 27, 2020 | 609,751 |  |  | 869,583 |  |  | $ | — |  |  | $ | 7.87 |  |  | 1.9
Exercisable at June 27, 2020 |  |  | 400,833 |  |  | $ | — |  |  | $ | 9.18 |  |  | 0.6
Additional Information Regarding Options Outstanding | Additional information regarding SARs outstanding and exercisable as of June 27, 2020, is as follows:
Range of Exercise Prices |  | Number Outstanding |  | Weighted Avg. Remaining Contractual Life (yrs.) |  | Weighted Avg. Exercise Price |  | Number Exercisable |  | Weighted Avg. Exercise Price
$4.40 – $7.90 |  | 347,500 |  |  | 2.1 |  | $ | 6.25 |  |  | — |  |  | $ | — |
7.91 – 9.91 |  | 328,750 |  |  | 0.6 |  | 8.17 |  |  | 207,500 |  |  | 8.17 |
9.92 – 11.34 |  | 193,333 |  |  | 0.1 |  | 10.26 |  |  | 193,333 |  |  | 10.26 |
$4.40 to $11.34 |  | 869,583 |  |  | 1.9 |  | $ | 7.87 |  |  | 400,833 |  |  | $ | 9.18 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock appreciation rights awards that were outstanding at the beginning and end of the year, and the number of stock appreciation rights awards that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration